Mark A. Bach

Sanofi (China) — China

Medicine · Health Sciences

24h-index2.4kcitations50works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Growth Hormone and Insulin-like Growth Factors(22), Metabolism, Diabetes, and Cancer(10), Prostate Cancer Diagnosis and Treatment(8), Urinary Bladder and Prostate Research(7), Pituitary Gland Disorders and Treatments(6)

Publications50 total

Regulation of Insulin, IGF-I, and IGF-II Gene Expression
2024· 2 cited
767-P: A Phase 1b/2a Study of the Safety and Tolerability of GSBR-1290, a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA), in Healthy Overweight/Obese Volunteers (HOV) and Participants with Type 2 Diabetes Mellitus (T2DM)
Diabetes·2024· 6 cited
754-P: A First-in-Human Single Ascending Dose Study of GSBR-1290, a Novel Small Molecule GLP-1 Receptor Agonist, in Healthy Volunteers
Diabetes·2023· 2 cited
Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency
Journal of the Endocrine Society·2021· 18 citedOpen Access
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study
CNS Drugs·2017· 10 cited
Dissecting the Workforce and Workplace for Clinical Endocrinology, and the Work of Endocrinologists Early in Their Careers
The Journal of Clinical Endocrinology & Metabolism·2011· 5 cited
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults
Annals of Internal Medicine·2008· 248 cited
BIODEGRADABLE MULCHING IN AN ORGANIC TOMATO PRODUCTION SYSTEM
Acta Horticulturae·2008· 38 cited
Lifeless Discussion
Science News·2005
THE ENDOCRINE SOCIETY ETHICS ADVISORY COMMITTEE: Ethical Aspects of Conflicts of Interests, October 2003
Endocrinology·2004· 11 citedOpen Access
The Endocrine Society Ethics Advisory Committee: Ethical Aspects of Conflicts of Interests, October 2003
Molecular Endocrinology·2004Open Access
The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture
Journal of the American Geriatrics Society·2004· 80 cited
Clinical Use of Growth Hormone Secretagogues
Humana Press eBooks·2003· 1 cited
A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis
The Journal of Urology·2003· 156 cited
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia
Urology·2003· 150 cited
Clinical Use of Growth Hormone Secretagogues
2000
Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years
Urology·1999· 26 cited
Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults
Journal of Bone and Mineral Research·1999· 48 citedOpen Access
IMPROVEMENT OF PRESSURE FLOW PARAMETERS WITH FINASTERIDE IS GREATER IN MEN WITH LARGE PROSTATES
The Journal of Urology·1999Open Access
IMPROVEMENT OF PRESSURE FLOW PARAMETERS WITH FINASTERIDE IS GREATER IN MEN WITH LARGE PROSTATES
The Journal of Urology·1999· 39 cited
page 1 of 3Next →

Frequent Co-authors

Glenn J. Gormley(9), Charles T. Roberts(6), Carolyn A. Bondy(5), Teuvo L.J. Tammela(5), Hans Hedlund(5), H.J. Rollema(5), Reginald C. Bruskewitz(5), Paul D. Miller(5), Carol Jacobsen(5), Marie‐Pierre Malice(5), Derek LeRoith(4), Paul Abrams(4), A. Matos‐Ferreira(4), J. Nørdling(4), Roger Kirby(4), Jens Thorup Andersen(4), Werner Schäfer(4), Daniel Levitt(4), David Krupa(3), Johnny Roy(3)